Literature DB >> 15739594

The effects of oral amino acid intake on ambulatory capacity in elderly subjects.

Roldano Scognamiglio1, Angelo Avogaro, Christian Negut, Roberto Piccolotto, Saula Vigili de Kreutzenberg, Antonio Tiengo.   

Abstract

BACKGROUND AND AIMS: The combination of high prevalence of inactivity in the older population, and high risk of ill-health and disability associated with inactivity, suggests that interventions that are successful in increasing levels of activity may have a great impact on population health in later life. With advancing age, the risk of developing serious nutritional deficiencies also increases. This study was designed to assess the effects of dietary amino acid supplementation on effort tolerance in healthy elderly subjects with reduced physical activity.
METHODS: Forty-four subjects (age > 65 years) with sedentary life-style and lower health-related quality of life were studied. Subjects, in an open-label fashion, received an oral amino acid mixture (AAM, 12 g/day) containing essential and non-essential amino acids for a 3-month period. Ambulatory dysfunction resulting in sedentary life-style was assessed by a 6-min walk test. A walking impairment questionnaire (WIQ) was used to evaluate self-perceived ambulatory dysfunction. Maximal isometric muscular strength of the right hand was measured during isometric exercise by a handgrip dynamometer.
RESULTS: The 6-min walk distance increased from 214.5 +/- 32 to 262.8 +/- 34.8 m (p < 0.001) after AAM treatment. The baseline scores on the three subscales of WIQ changed significantly during treatment: WIQ distance increased from 56.2 +/- 12.9 to 66.3 +/- 12.8% (p < 0.001); WIQ speed from 52 +/- 12.6 to 69.2 +/- 14.8% (p < 0.001) and WIQ stairs from 74.4 +/- 22.6 to 94.2 +/- 25% (p < 0.001), as did maximal isometric muscular strength (16.6 +/- 2.4 vs 19.2 +/- 2.2 kg, p < 0.001). Changes in plasma glucose (+11 +/- 11 mg/dL), total cholesterol (0 +/- 39 mg/dL), HDL cholesterol (0 +/- 17 mg/dL), and triglycerides (-11 +/- 58 mg/dL) were not significant between baseline and AAM.
CONCLUSIONS: An oral amino acid supplement, as used in this pilot study, improves ambulatory capacity and maximal isometric muscle strength in elderly subjects without affecting the main metabolic parameters. Amino acid supplementation may thus represent useful non-pharmacological intervention to maintain physical fitness in these subjects.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15739594     DOI: 10.1007/bf03327399

Source DB:  PubMed          Journal:  Aging Clin Exp Res        ISSN: 1594-0667            Impact factor:   3.636


  5 in total

Review 1.  Evidence-based roads to the promotion of health in old age.

Authors:  P Ljubuncic; A Globerson; A Z Reznick
Journal:  J Nutr Health Aging       Date:  2008-02       Impact factor: 4.075

Review 2.  Potential application of essential amino Acid supplementation to treat sarcopenia in elderly people.

Authors:  Gregory C Henderson; Brian A Irving; K Sreekumaran Nair
Journal:  J Clin Endocrinol Metab       Date:  2009-05       Impact factor: 5.958

3.  Effect of amino acid supplementation on muscle mass, strength and physical function in elderly.

Authors:  Elisabet Børsheim; Quynh-Uyen T Bui; Sandrine Tissier; Hisamine Kobayashi; Arny A Ferrando; Robert R Wolfe
Journal:  Clin Nutr       Date:  2008-03-04       Impact factor: 7.324

4.  Supplementation of l-Alanyl-l-Glutamine and Fish Oil Improves Body Composition and Quality of Life in Patients With Chronic Heart Failure.

Authors:  Christina Wu; Tomoko S Kato; Ruiping Ji; Cynthia Zizola; Danielle L Brunjes; Yue Deng; Hirokazu Akashi; Hilary F Armstrong; Peter J Kennel; Tiffany Thomas; Daniel E Forman; Jennifer Hall; Aalap Chokshi; Matthew N Bartels; Donna Mancini; David Seres; P Christian Schulze
Journal:  Circ Heart Fail       Date:  2015-08-12       Impact factor: 8.790

Review 5.  Muscle wasting and resistance of muscle anabolism: the "anabolic threshold concept" for adapted nutritional strategies during sarcopenia.

Authors:  Dominique Dardevet; Didier Rémond; Marie-Agnès Peyron; Isabelle Papet; Isabelle Savary-Auzeloux; Laurent Mosoni
Journal:  ScientificWorldJournal       Date:  2012-12-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.